Is the STOP-BANG Predictive of Worsening OSA in the Early Postop Period in Patients Undergoing TJA?
NCT ID: NCT02123225
Last Updated: 2017-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
93 participants
OBSERVATIONAL
2013-12-31
2017-05-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypotheses:
1. \- Postoperative sleep apnea parameters will be worse when compared to baseline in patients with higher scores on the STOP-BANG.
2. \- A higher STOP-BANG score will be predictive of worsening sleep apnea parameters in patients undergoing Total Knee Arthroscopy (TKA).
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this prospective observational cohort study is to determine in TKA patients if the score on the STOP-BANG (\<3, ≥3 to \<5, or ≥5) is predictive of worsening sleep apnea parameters (AHI, time with SPO2 \<90% \& 85% \[T90 \& T85\], lowest oxygen saturation \[LSAT\], \& number of central apneas) during the first three days after surgery. The investigators propose to enroll N = 168 patients undergoing TKA at NMCSD who are receiving multimodal anesthesia/analgesia for surgery. Patients will complete a baseline unattended sleep study prior to surgery then again for the first three days after surgery. Patients will be categorized into three groups based on their STOP-BANG score (\<3, ≥3 to \<5, or ≥5) and the investigators will first compare the groups to identify if there are differences between baseline and postoperative sleep apnea parameters based on the STOP-BANG groups (\<3, ≥3 to \<5, or ≥5). If differences are found the investigators will use multiple regression analysis to determine if the STOP-BANG scores or categories and/or other covariates (i.e., comorbidity index, total morphine equivalents) are predictive of worsening sleep apnea during the first three days after surgery.
Results of this study may help improve patient safety by allowing us to identify which group of TKA patients with undiagnosed OSA may require more intensive postoperative monitoring and therapy (i.e, ICU admission, need for continuous end-tidal CO2 monitoring, postoperative positive airway pressure therapy) or change in the analgesic plan.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for primary or revision TKA
* Able to read and understand the consent
* Able to complete an unattended OSA PM examination at home 1-60 days prior to surgery and for three days postoperatively
Exclusion Criteria
* Significant comorbid medical conditions that may degrade the accuracy of PM (moderate to severe pulmonary disease, neuromuscular disease, or congestive heart failure)
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Naval Medical Center, San Diego
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dennis Spence
Regional Director, Nursing Research, NAVMEDWEST Region
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dennis L Spence, PhD
Role: PRINCIPAL_INVESTIGATOR
United States Naval Medical Center, San Diego
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Naval Medical Center San Diego
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMCSD.2013.0045
Identifier Type: -
Identifier Source: org_study_id